effects of semaglutide on chronic kidney disease Long-term outcomes in obesity and cardiovascular in the SELECT trial The Effects of Semaglutide on

Side effects are usually mild to moderate, and in the clinical trials more than 90% of those treated with semaglutide / Wegovy and tirzepatide / Zepbound were able to stay on the medications

This gives you roughly 12-16 unique spots on the abdomen alone before you need to revisit any area

What are the cons of taking Mounjaro

While specific requirements can vary by provider, clients are commonly considered good candidates if they meet one of the following criteria: A BMI of 30 or higher (classified as obesity) A BMI of 27 or higher with at least one weight-related health condition, such as high blood pressure, high cholesterol, type 2 diabetes, prediabetes, or sleep apnea In addition, candidates should be in overall stable health, not pregnant or breastfeeding, and not have a personal or family history of certain medical conditions such as medullary thyroid carcinoma or MEN2 (Multiple Endocrine Neoplasia type 2)

Your provider may also recommend against semaglutide if you have a history of pancreatitis, impaired kidney function, or take medications whose absorption could be affected by delayed gastric emptying

Tirzepatide is a dual GLP-1 and GIP receptor agonist, often described as a twincretin. It is a single synthetic peptide designed to activate two incretin receptors simultaneously rather than one